Please try another search
DNA Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally. Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing. The company also provides microarray services, such as DNA and microarray RNA analysis; Fluidigm BioMark System, an automated PCR/qPCR system; TaqMan assay; and SNaPshot assay. In addition, it offers Covid-19 diagnostic kits; DNAGPS, a personal genomics (PGX) solution; and AccuID, a personal identification microarray system. DNA Link, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Mun-Hak Kim | 58 | - | Director |
Young-Gu Ji | 58 | - | Independent Outside Director |
Hyung-Bae Kim | 61 | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review